Despite Scientist Shortage, Future Ph.D.'s Fear Joblessness

With funding opportunities dwindling in an unpredictable economic climate, graduate students planning to earn their Ph.D.'s in the next two years face a host of uncertainties, according to Betty Vetter, director of the Washington, D.C.-based Commission on Professionals in Science and Technology. Although the National Science Foundation and other agencies are anticipating a shortage of Ph.D. scientists beginning in the mid-1990s, students who will earn their doctorates before then are bracing th

Written byLisa Simon
| 7 min read

Register for free to listen to this article
Listen with Speechify
0:00
7:00
Share

The commission predicts that in 1993, approximately 7,300 U.S. citizens will complete Ph.D.'s in the natural sciences. This figure includes approximately 4,500 Ph.D.'s in the life sciences, 1,200 in chemistry, and 675 in astronomy and physics. These predictions, Vetter says, are based on similar figures compiled in recent years: "The numbers have been very steady for the last 10 years, and we don't see any significant change coming soon."

Sandra J. Lazzarini, a graduate student in neuroscience at the University of Massachusetts, Amherst, is among those 7,300 future scientists who will be thrust into a fragile job market in 1993. She and her peers are about to find out the hard way how different the "real world" is from life as a graduate student. "You can do what you really want to do while you're training," Lazzarini says.

As a graduate student, the neuroscientist notes, she doesn't have to worry ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies